Clinical Trial

Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in Children

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 13, 2024 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn the plasma concentration of isavuconazole in pediatric patients. It will also learn about the relationship of isavuconazole plasma concentrations to efficacy and safety in pediatric patients. The main questions it aims to answer are: What is the plasma concentration after using isavuconazole in pediatric patients? What is the effective range of plasma concentration of isavuconazole in pediatric patients? What is the safe range of plasma concentration of isavuconazole in pediatric patients? Researchers will measure the plasma concentration of isavuconazole to see whether it is appropriate. Participants will: Take drug isavuconazole as prescribed by the doctor; 1mL of blood is drawn 30min before the next dose.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-01.
Status change: Not Yet Recruiting → Recruiting 2024-12-09
Trial Details
NCT Number NCT06440915
Lead Sponsor Shanghai Children's Medical Center
Conditions Aspergillosis Invasive, Mucormycosis
Enrollment 200 participants
Start Date 2024-06-06
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-13